FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036865617> ?p ?o ?g. }

• W3036865617 abstract "Abstract Background Higher than expected adolescent pregnancy high rates continue globally, with repeated unplanned pregnancy (UP) in this age group is a public health problem. In Brazil, 16% of pregnancies occur in adolescents under 18 years old, with high maternal morbidity and mortality rates in this age group. Effective and safe contraception is required to reduce UP rates. The objective of our study is to evaluate acceptance of etonogestrel (ENG)-releasing subdermal contraceptive implant after childbirth, before discharge, as well as clinical performance up to one year after placement. Comparison between teenagers who opt for ENG-implant versus other contraceptive methods after childbirth will be also evaluated, specifically regarding UP, continuation and discontinuation rates and reasons, body composition, pelvic ultrasound characteristics and user satisfaction. Methods A non-randomized open-label trial will be conducted with teenagers after childbirth and followed up to one year at the Women’s Hospital, University of Campinas (UNICAMP), Campinas, Brazil. The study group will consist of patients who accepted to use ENG-implant and placed before discharge. The comparison group will include adolescents who choose to use other contraceptive methods at the first postpartum visit (42 ± 3 days after childbirth). All women will follow-up at 40–60 days postpartum, as well as, at 6 and 12 months post-enrollment. Patient satisfaction, contraceptive effectiveness, reasons of discontinuation, continuation rate and body composition will be evaluated. Transvaginal ultrasound and electric bio impedance tests will be performed at all follow-up appointments. A 5% significance level was assumed, as well as, a sampling error (absolute) for 10% prevalence. The sample size was calculated at n = 100, obtaining an estimate of 50 to 70 adolescents who would accept the method offered, according to the prevalence and sample error assumed. Discussion Long-acting reversible contraceptive (LARC) methods include subdermal implants and intrauterine contraceptives, are considered first line contraception for teenagers. Immediate postpartum use is a safe option, which significantly reduces rates of repeated UP and all the undesirable consequences inherent to this process. Trial registration This study was approved by the Ethics and Research Commission of UNICAMP (CAAE: 92869018.5.0000.5404) and the Brazilian Registry of Clinical Trials (REBEC): http://www.ensaiosclinicos.gov.br/rg/RBR-4z7bc6 , (number 2.901.752)." @default.
• W3036865617 created "2020-06-25" @default.
• W3036865617 creator A5009424411 @default.
• W3036865617 creator A5018766511 @default.
• W3036865617 creator A5068769642 @default.
• W3036865617 creator A5083304337 @default.
• W3036865617 date "2020-06-23" @default.
• W3036865617 modified "2023-10-18" @default.
• W3036865617 title "ENG-releasing subdermal implants in postpartum teenagers – an open-label trial study protocol" @default.
• W3036865617 cites W1990402171 @default.
• W3036865617 cites W1992623911 @default.
• W3036865617 cites W1996605975 @default.
• W3036865617 cites W2004369533 @default.
• W3036865617 cites W2011494015 @default.
• W3036865617 cites W2015987333 @default.
• W3036865617 cites W2029657785 @default.
• W3036865617 cites W2067862373 @default.
• W3036865617 cites W2078142494 @default.
• W3036865617 cites W2134712068 @default.
• W3036865617 cites W2160958773 @default.
• W3036865617 cites W2162085650 @default.
• W3036865617 cites W2166023752 @default.
• W3036865617 cites W2179114792 @default.
• W3036865617 cites W2209911173 @default.
• W3036865617 cites W2238616464 @default.
• W3036865617 cites W2285291906 @default.
• W3036865617 cites W2418264519 @default.
• W3036865617 cites W2495873475 @default.
• W3036865617 cites W2553496334 @default.
• W3036865617 cites W2560981905 @default.
• W3036865617 cites W2575512866 @default.
• W3036865617 cites W2587609987 @default.
• W3036865617 cites W2597998766 @default.
• W3036865617 cites W2792901095 @default.
• W3036865617 cites W2888606847 @default.
• W3036865617 cites W3012023428 @default.
• W3036865617 cites W4213280137 @default.
• W3036865617 doi "https://doi.org/10.1186/s12978-020-00952-5" @default.
• W3036865617 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7310555" @default.
• W3036865617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32576199" @default.
• W3036865617 hasPublicationYear "2020" @default.
• W3036865617 type Work @default.
• W3036865617 sameAs 3036865617 @default.
• W3036865617 citedByCount "3" @default.
• W3036865617 countsByYear W30368656172021 @default.
• W3036865617 countsByYear W30368656172022 @default.
• W3036865617 countsByYear W30368656172023 @default.
• W3036865617 crossrefType "journal-article" @default.
• W3036865617 hasAuthorship W3036865617A5009424411 @default.
• W3036865617 hasAuthorship W3036865617A5018766511 @default.
• W3036865617 hasAuthorship W3036865617A5068769642 @default.
• W3036865617 hasAuthorship W3036865617A5083304337 @default.
• W3036865617 hasBestOaLocation W30368656171 @default.
• W3036865617 hasConcept C131872663 @default.
• W3036865617 hasConcept C138816342 @default.
• W3036865617 hasConcept C141071460 @default.
• W3036865617 hasConcept C159110408 @default.
• W3036865617 hasConcept C168563851 @default.
• W3036865617 hasConcept C187212893 @default.
• W3036865617 hasConcept C2775944032 @default.
• W3036865617 hasConcept C2776283161 @default.
• W3036865617 hasConcept C2777548101 @default.
• W3036865617 hasConcept C2778715236 @default.
• W3036865617 hasConcept C2779076696 @default.
• W3036865617 hasConcept C2779234561 @default.
• W3036865617 hasConcept C2779703513 @default.
• W3036865617 hasConcept C2781197234 @default.
• W3036865617 hasConcept C2908647359 @default.
• W3036865617 hasConcept C29456083 @default.
• W3036865617 hasConcept C2986817661 @default.
• W3036865617 hasConcept C54355233 @default.
• W3036865617 hasConcept C71924100 @default.
• W3036865617 hasConcept C86803240 @default.
• W3036865617 hasConcept C99454951 @default.
• W3036865617 hasConceptScore W3036865617C131872663 @default.
• W3036865617 hasConceptScore W3036865617C138816342 @default.
• W3036865617 hasConceptScore W3036865617C141071460 @default.
• W3036865617 hasConceptScore W3036865617C159110408 @default.
• W3036865617 hasConceptScore W3036865617C168563851 @default.
• W3036865617 hasConceptScore W3036865617C187212893 @default.
• W3036865617 hasConceptScore W3036865617C2775944032 @default.
• W3036865617 hasConceptScore W3036865617C2776283161 @default.
• W3036865617 hasConceptScore W3036865617C2777548101 @default.
• W3036865617 hasConceptScore W3036865617C2778715236 @default.
• W3036865617 hasConceptScore W3036865617C2779076696 @default.
• W3036865617 hasConceptScore W3036865617C2779234561 @default.
• W3036865617 hasConceptScore W3036865617C2779703513 @default.
• W3036865617 hasConceptScore W3036865617C2781197234 @default.
• W3036865617 hasConceptScore W3036865617C2908647359 @default.
• W3036865617 hasConceptScore W3036865617C29456083 @default.
• W3036865617 hasConceptScore W3036865617C2986817661 @default.
• W3036865617 hasConceptScore W3036865617C54355233 @default.
• W3036865617 hasConceptScore W3036865617C71924100 @default.
• W3036865617 hasConceptScore W3036865617C86803240 @default.
• W3036865617 hasConceptScore W3036865617C99454951 @default.
• W3036865617 hasFunder F4320320997 @default.
• W3036865617 hasIssue "1" @default.
• W3036865617 hasLocation W30368656171 @default.
• W3036865617 hasLocation W30368656172 @default.
• W3036865617 hasLocation W30368656173 @default.

• next